Navigation Links
Plant hormone has dual role in triggering flower formation, Penn study finds
Date:5/8/2014

ytochrome enzyme and has been shown to play a role in breaking down gibberellin. Further experiments showed that in plants that lost ELA1 function, flowers formed much later than normal.

The researchers also found that plants that lacked LEAFY had high levels of gibberellin, and plants engineered to produce high levels of LEAFY had lower levels of the hormone and were also shorter with greater levels of chlorophyll characteristics of gibberellin deficiency.

"At first we were confused because gibberellin was supposed to promote all of this activity that leads to flower formation," Wagner said. "Then when we found a direct target of LEAFY that is linked to gibberellin catabolism, that gave us the clue that gibberellin must have a role in inhibiting flower formation as well."

Plants that were genetically modified to not produce gibberellin properly and plants that were treated with a gibberellin inhibitor showed signs of a delayed first transition to inflorescence but accelerated signs of flower formation. Spraying the plants with gibberellin had the opposite effect.

The results suggested that the two transition steps that lead plants to produce flowers might be regulated distinctly, both involving gibberellin. While gibberellin promotes the first transition, in which plants stop producing stems and leaves and produce an inflorescence, it inhibited the second stage, in which flowers were formed.

The mechanism, the Penn team showed, involves rising and then falling levels of gibberellin. High levels cause the plant to end the vegetative phase of development. At that point, LEAFY and ELA1 activity cause gibberellin to break down. Freed from the inhibitory effects of the hormone, a suite of proteins are activated that trigger flower formation.

"When it comes to determining the number of flowers formed and when they are formed, we think this pathway is at the forefront," Wagner said.

Farmers already use gi
'/>"/>

Contact: Katherine Unger Baillie
kbaillie@upenn.edu
215-898-9194
University of Pennsylvania
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Simulated model of eyes 3D structure facilitates stem cells transplant
2. Plantable containers show promise for use in groundcover production, landscaping
3. Light-sensitive eyes in plants
4. Putting the endoparasitic plants Apodanthaceae on the map
5. Plants send out signals attracting harmful bacteria, MU study finds
6. How a plant beckons the bacteria that will do it harm
7. Study finds long-term survival of human neural stem cells transplanted into primate brain
8. Plants with dormant seeds give rise to more species
9. Rapid and accurate mRNA detection in plant tissues
10. Genetic study tackles mystery of slow plant domestications
11. Biologists develop nanosensors to visualize movements and distribution of plant hormone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... decade, Steve Stice has dedicated his research using embryonic ... degenerative diseases and debilitating injuries. His most recent discovery, ... stem cells, could now aid in national security. ... of Georgia animal science professor and Georgia Research Alliance ...
... CHAMPAIGN, Ill. -- By placing quantum dots on ... University of Illinois have demonstrated enhanced fluorescence intensity ... applications include high-brightness,light-emitting diodes, optical switches and personalized, ... a new way, said Brian Cunningham, a professor ...
... have discovered that a specific mutation of the COX2 ... of ovarian cancer, increasing womens susceptibility to developing the ... the findings are confirmed by further studies, it might ... as aspirin and ibuprofen, which are used already for ...
Cached Biology News:New use for stem cells found in war on terrorism 2New use for stem cells found in war on terrorism 3Researchers set new record for brightness of quantum dots 2Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer 2Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer 3
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to ... the Lyon County Fair to be held August 5-9 in Marshall. The Ralco Enrichment ... meals come from and how agriculture impacts their daily lives. This unique exhibit also ...
(Date:7/30/2015)... ... , ... The 2015 Market Research Report on the Global Propanol Industry ... Propanol market with a focus on the Chinese situation. Major companies included in the ... Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , The report ...
(Date:7/30/2015)...   Senomyx , Inc. (NASDAQ: SNMX ), ... discover, develop, and commercialize novel flavor ingredients for the ... results for the second quarter 2015. ... on track to achieve our commercial and financial goals," ... the Company. "Since our last quarterly earnings report, our ...
(Date:7/30/2015)... 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... the second $1.0M tranche under a previously awarded ... valued at up to $3.0 million to support ... as a potential medical countermeasure to mitigate acute ... awarded an initial $1.0 million under this grant ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... DIEGO, Oct. 31 Optimer Pharmaceuticals, Inc. (Nasdaq: ... from fidaxomicin,s North American phase 3 study at the ... America (IDSA) in Philadelphia, PA. , (Logo: ... of the Division of Infectious Diseases, Chair of the ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a ... today that the Company will host a conference call ... Thursday, November 5, 2009 to discuss its third quarter ... participate in the call, please dial 800-860-2442 (domestic) or ...
... Pa., Oct. 30 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corporation (Nasdaq: BJGP ) ("BMP ... , , -- Oppenheimer 20th Annual Healthcare Conference, to ... the Waldorf=Astoria hotel in New York. Management is scheduled, ... 3, and meet with, institutional investors ...
Cached Biology Technology:Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 2Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 3Additional Data From Fidaxomicin's Phase 3 Study for Clostridium Difficile Infection (CDI) Presented at IDSA Annual Meeting 4BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2009 Financial Results on November 5, 2009 2BMP Sunstone Announces November Investor Conference Participation 2
...
... PCR Spots, Oligo Spots and complementary RNA ... microarray experiments. Use for glass array printing ... for reverse transcription, cDNA labeling, hybridization stringency ... Control PCR Spots and Oligo Spots, ...
MOUSE ANTI DUCK IgY LIGHT CHAIN...
MOUSE ANTI S. MUTANS PEPTIDOGLYCAN...
Biology Products: